Citi analyst Christopher Allen raised the firm’s price target on Stifel Financial (SF) to $115 from $110 and keeps a Neutral ...

Fintel reports that on January 10, 2025, Stifel downgraded their outlook for IGM Biosciences (NasdaqGS:IGMS) from Buy to Hold ...

周五，Stifel分析师调整了对Repare Therapeutics（纳斯达克股票代码：RPTX）股票的展望，将目标价从之前的4.00美元下调至3.00美元，同时仍维持对该股的买入评级。目前，该公司股价为1.31美元，市值约为5600万美元。

周五，Stifel分析师维持Align Technology股票的买入评级，目标价保持在275.00美元。这一积极立场源于该公司正在进行的重组计划，分析师认为这将为实现2025年每股收益 (EPS)超过10美元的预期目标提供更多时间。Align Technology以其Invisalign正畸设备而闻名，同时还持有每股14美元的大量现金。

We recently compiled a list of the 13 AI News and Ratings on Wall Street’s Radar. In this article, we are going to take a ...

In a report released yesterday, Mathew Blackman from Stifel Nicolaus maintained a Buy rating on Senseonics Holdings (SENS – Research Report), ...

The highly anticipated Assassin's Creed Shadows, initially slated for release in November, has now been postponed for the ...

An index of St. Louis-area publicly traded stocks underperformed the broad stock market averages in 2024. The equally ...

Stifel analysts raised their price target to $31.00 from $26.00 and reiterated a Buy rating on Rocket Lab ( RKLB, Financial) ...

In a report released today, Cole McGill from Stifel Nicolaus maintained a Buy rating on Lithium Americas Corp. (LAC – Research Report), with a ...

PRIEST RIVER — Senior Palmer Coleman and junior Ian Lamanna hit a one free throw each with less than two seconds to go as the ...

The stock fell 6.2% to $140.14 in New York, marking the biggest single-day decline in four months. Though the Nvidias latest ...